MUC16 and hydrops fetalis: However, while substantial evidence supports the utility of CA125 for risk stratification, monitoring, and guiding HF depletive therapy [4, 5], it remains unclear whether this glycoprotein merely serves as a surrogate marker of fluid overload and inflammation or plays an active role in the pathobiology of the disease.